כל המחקרים
גיוסשלב 3התערבותי

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

This study is testing a medicine called guselkumab in children and teenagers (aged 2 to 17) who have moderately to severely active Crohn's disease. Crohn's disease can cause inflammation in the gut, leading to symptoms like tummy pain and frequent toilet trips. The main aim is to see how effective guselkumab is over 52 weeks (about one year) for patients who showed improvement in their symptoms after the first 12 weeks of treatment. Researchers will use special tests, like internal cameras (endoscopy), to check the healing of the gut lining. This is a Phase 3 study, meaning it's a larger trial happening after initial safety and effectiveness tests, bringing it closer to potentially being available to more patients.

במבט חטוף

סטטוס
גיוס
שלב
שלב 3
נותן חסות
יאנסן מחקר ופיתוח, LLC
יעד הרשמה
120
התחל
13 Mar 2024
השלמה משוערת
14 Aug 2028

על מה המחקר הזה?

Crohn's disease is a condition that causes long-term inflammation in your digestive system. This can lead to symptoms like tummy pain, diarrhoea, weight loss, and feeling very tired. For some children and teenagers, these symptoms can be quite severe and impact their daily lives.

This particular study is looking into a medicine called guselkumab. It’s being tested in young people aged 2 to 17 who have Crohn’s disease that isn't well controlled by other treatments, or who haven't been able to tolerate them. The study wants to find out if guselkumab can effectively reduce the inflammation and symptoms caused by Crohn’s after one year of treatment, especially for those who show early improvement.

The researchers will be monitoring participants closely to see how well the medicine helps heal the gut lining. This information is important because it could help doctors understand if guselkumab is a safe and effective new option for treating Crohn's disease in young people in the future.

נקודות עיקריות

  • This study is for children and teenagers (2-17 years old) with Crohn's disease.
  • It tests a medicine called guselkumab over one year.
  • Aims to see if it helps reduce symptoms and heal the gut lining.
  • It's for those whose current treatments haven't worked well.
  • Participants will have regular medical check-ups and tests.

מי עשוי להיות זכאי?

To join this study, you (or your child) must have been diagnosed with Crohn's disease that currently causes moderate to severe symptoms. Doctors will confirm this using a special scoring system and internal camera tests (endoscopy) to check for active inflammation in the gut.

You would also need to have tried other common treatments for Crohn's disease in the past, such as certain immune-suppressing medicines or steroids, and either they didn't work well enough, stopped working, or caused too many side effects. Alternatively, you might be eligible if you've developed a dependency on steroid medication, or if nutritional therapy hasn't been effective.

However, some things would mean you can't take part. For example, if your Crohn's disease has caused complications like blockages in the gut that might need surgery soon, or if you have an abscess (a collection of pus). You also couldn't join if you’ve had certain types of bowel surgery in the last few months.

האם מחקר זה יכול להתאים לך?

ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.

  1. I have been diagnosed with Crohn's disease.
  2. My Crohn's disease currently causes moderate to severe symptoms.
  3. I have tried other Crohn's medicines (like immune suppressors or steroids) and they didn't work well, stopped working, or caused bad side effects.
  4. I haven't had any recent surgeries on my bowel (within the last few months).
  5. I do not have any abscesses or severe bowel blockages due to Crohn's.
ענה על כל שאלה כדי לראות את התוצאה שלך.

מה כרוך בהשתתפות?

If you decide to take part in this study, you would first go through some checks to make sure the study is right for you. This might involve physical exams, blood tests, and an endoscopy (a procedure where a thin, flexible tube with a camera is used to look inside your digestive system) to confirm the level of activity of your Crohn's disease. If you qualify, you or your child would then receive the study medication, guselkumab. The exact way this medicine is given (e.g., by injection) and how often would be explained to you in detail by the study team. You would have regular visits to the clinic for assessments, which include checking your symptoms, blood tests, and sometimes further endoscopies. The study aims to follow how you respond to the treatment over 52 weeks (about one year).

סיכונים ותועלות פוטנציאליים

Taking part in this study may offer potential benefits, such as receiving a new investigational treatment for your Crohn’s disease that might improve your symptoms and gut health. However, like all medicines, guselkumab could have side effects, and some might not be known yet. The study team will monitor you closely for any unwanted effects. You have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

מיקומים (85)

  • מרכז רפואי סידרס סיני
    מיקוד מאומת
    לוס אנג'לס, ארצות הברית· גיוס
  • Connecticut Children's Medical Center
    מיקוד מאומת
    הרטפורד, ארצות הברית· הושלם
  • Emory University
    מיקוד מאומת
    אטלנטה, ארצות הברית· גיוס
  • Children's Center for Digestive Health Care
    מיקוד מאומת
    אטלנטה, ארצות הברית· גיוס
  • Riley Hospital for Children
    מיקוד מאומת
    אינדיאנפוליס, ארצות הברית· הושלם
  • Boston Childrens Hospital
    מיקוד מאומת
    בוסטון, ארצות הברית· גיוס
  • Goryeb Children's Hospital
    מיקוד מאומת
    Morristown, United States· גיוס
  • Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center
    מיקוד מאומת
    ניו יורק, ארצות הברית· גיוס
  • Icahn School of Medicine at Mount Sinai
    מיקוד מאומת
    ניו יורק, ארצות הברית· גיוס
  • Columbia University Medical Center
    מיקוד מאומת
    ניו יורק, ארצות הברית· הושלם
  • The Children's Medical Center of Dayton
    מיקוד מאומת
    Dayton, United States· הושלם
  • בית החולים לילדים של פילדלפיה
    מיקוד מאומת
    פילדלפיה, ארצות הברית· גיוס

שאלות נפוצות

What is guselkumab?

Guselkumab is an investigational medicine being tested to see if it can help reduce inflammation in Crohn’s disease.

כמה זמן יימשך המחקר?

The main part of this study will last for about 52 weeks, which is roughly one year.

Will I know if I'm getting the active medicine or a placebo?

The study design will be explained fully by the research team; in some phases of trials, it's common for participants to receive the active drug rather than a placebo in studies of this type.

What happens if guselkumab doesn't work for me?

The study team will regularly monitor your condition, and if the treatment isn't working or your condition worsens, they will discuss your options for further care.

האם אני צריך לשלם כדי להשתתף במחקר?

No, all study-related treatments and assessments are usually provided free of charge.

כיצד לגלות עוד

איש קשר ללימודים

תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.

מעוניינים להשתתף?

רשום את התעניינותך

שתף את הפרטים שלך וצוות המחקר עבור "A Study of Guselkumab in Pediatric Participants With Moderat…" ייצרו איתך קשר אם אתה עשוי להיות זכאי. תמיד התייעץ עם הרופא שלך לפני שאתה מסכים להשתתף.

דיון

דיון קהילתי

מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.